A Randomized, Double-blind, Double-dummy, 2-arm Parallel-group, Multicenter 24-week Study Comparing the Efficacy and Safety of AVE0010 to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 and Not Adequately Controlled With Metformin.
Phase of Trial: Phase III
Latest Information Update: 13 Oct 2016
At a glance
- Drugs Lixisenatide (Primary) ; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Sanofi
- 07 May 2012 Actual patient number 319 added as reported by ClinicalTrials.gov.
- 06 May 2011 Actual end date (1 Apr 2011) added as reported by ClinicalTrials.gov.
- 29 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.